The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective cohort study on the safety and efficacy of bevacizumab for metastatic colorectal cancer patients: The HGCSG0801 study—Analysis of bevacizumab beyond progression (BBP).
Hiraku Fukushima
No relevant relationships to disclose
Satoshi Yuki
No relevant relationships to disclose
Yoshimitsu Kobayashi
No relevant relationships to disclose
Kazuteru Hatanaka
No relevant relationships to disclose
Takaya Kusumi
No relevant relationships to disclose
Ayumu Hosokawa
No relevant relationships to disclose
Takuto Miyagishima
No relevant relationships to disclose
Satoshi Takeuchi
No relevant relationships to disclose
Mineo Kudo
No relevant relationships to disclose
Yoshito Komatsu
No relevant relationships to disclose